Skip to main content
An official website of the United States government
Español
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Gardasil 9

(GAR-duh-sil …)
A vaccine that is FDA-approved for use in females and males aged 9 to 45 years to protect against infection with nine types of human papillomavirus (HPV). Gardasil 9 protects against low-risk HPV types 6 and 11, which cause most genital warts, and against high-risk HPV types 16, 18, 31, 33, 45, 52, and 58, which cause most precancerous lesions and cancers of the cervix, vagina, vulva, anus, and head and neck, including the oropharynx. Gardasil 9 may also prevent HPV-related cancer of the penis. Also called recombinant human papillomavirus nonavalent vaccine.
Search NCI's Dictionary of Cancer Terms